Danish Pharmaceuticals & Biotech Leverage Leaders

Genmab

Market Cap: DKK 130.3b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

ALK-Abelló

Market Cap: DKK 49.9b

Operates as an allergy solutions company in Europe, North America, and internationally.

Bavarian Nordic

Market Cap: DKK 15.5b

Develops, manufactures, and supplies life-saving vaccines.

H. Lundbeck

Market Cap: DKK 41.5b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Zealand Pharma

Market Cap: DKK 30.4b

A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.